145 related articles for article (PubMed ID: 10739697)
21. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
Park CH; Chang JY; Hahm ER; Park S; Kim HK; Yang CH
Biochem Biophys Res Commun; 2005 Mar; 328(1):227-34. PubMed ID: 15670774
[TBL] [Abstract][Full Text] [Related]
22. A common human skin tumour is caused by activating mutations in beta-catenin.
Chan EF; Gat U; McNiff JM; Fuchs E
Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
[TBL] [Abstract][Full Text] [Related]
23. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
[TBL] [Abstract][Full Text] [Related]
24. [Mutation analysis of the beta-catenin gene in epithelial carcinomas of the ovaries].
Tanyi J; Páy A; Rigó J; Nagy B; Papp Z
Orv Hetil; 2000 May; 141(21):1115-9. PubMed ID: 10876313
[TBL] [Abstract][Full Text] [Related]
25. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
Dihlmann S; Siermann A; von Knebel Doeberitz M
Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
[TBL] [Abstract][Full Text] [Related]
26. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer.
Dimberg J; Hugander A; Sirsjö A; Söderkvist P
Anticancer Res; 2001; 21(2A):911-5. PubMed ID: 11396184
[TBL] [Abstract][Full Text] [Related]
27. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.
Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042
[TBL] [Abstract][Full Text] [Related]
28. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.
Bordonaro M; Mariadason JM; Aslam F; Heerdt BG; Augenlicht LH
Cell Growth Differ; 1999 Oct; 10(10):713-20. PubMed ID: 10547075
[TBL] [Abstract][Full Text] [Related]
29. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
[TBL] [Abstract][Full Text] [Related]
30. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells.
Rios-Doria J; Kuefer R; Ethier SP; Day ML
Cancer Res; 2004 Oct; 64(20):7237-40. PubMed ID: 15492240
[TBL] [Abstract][Full Text] [Related]
31. Negative regulation of beta-catenin/Tcf signaling by naringenin in AGS gastric cancer cell.
Lee JH; Park CH; Jung KC; Rhee HS; Yang CH
Biochem Biophys Res Commun; 2005 Sep; 335(3):771-6. PubMed ID: 16102728
[TBL] [Abstract][Full Text] [Related]
32. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.
Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y
Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519
[TBL] [Abstract][Full Text] [Related]
33. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.
von Kries JP; Winbeck G; Asbrand C; Schwarz-Romond T; Sochnikova N; Dell'Oro A; Behrens J; Birchmeier W
Nat Struct Biol; 2000 Sep; 7(9):800-7. PubMed ID: 10966653
[TBL] [Abstract][Full Text] [Related]
34. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
[TBL] [Abstract][Full Text] [Related]
35. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling.
Park CH; Hahm ER; Park S; Kim HK; Yang CH
FEBS Lett; 2005 May; 579(13):2965-71. PubMed ID: 15893313
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation.
Mariadason JM; Bordonaro M; Aslam F; Shi L; Kuraguchi M; Velcich A; Augenlicht LH
Cancer Res; 2001 Apr; 61(8):3465-71. PubMed ID: 11309309
[TBL] [Abstract][Full Text] [Related]
37. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor.
Chesire DR; Isaacs WB
Oncogene; 2002 Dec; 21(55):8453-69. PubMed ID: 12466965
[TBL] [Abstract][Full Text] [Related]
38. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
39. Beta-catenin mutations in human prostate cancer.
Voeller HJ; Truica CI; Gelmann EP
Cancer Res; 1998 Jun; 58(12):2520-3. PubMed ID: 9635571
[TBL] [Abstract][Full Text] [Related]
40. beta-catenin signaling and cancer.
Morin PJ
Bioessays; 1999 Dec; 21(12):1021-30. PubMed ID: 10580987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]